Tempus AI Falls 15% on Weak Q4 but EBITDA View Strong: Buy the Dip?

Tempus AI (TEM) , an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest since its successful IPO in June 2024.  The stock had been on a strong upward trend but its weaker-than-anticipated fourth-quarter 2024 results, released on Feb. 24, resulted in a sharp decline, with shares dropping more than 15% the next day. Concerns over revenue timing shifts and market conditions resulted in the downturn.Nevertheless, with an increased 2025 revenue forecast of $1 ...